Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22260988 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents According to Different Vaccination Schedules
Condition: Meningococcal Disease
Interventions: Biological: rMenB+OMV NZ;   Biological: Placebo

Indicates status has not been verified in more than two years